Articles for Hikma Pharmaceuticals (LSE: HIK)

2 growth stocks for the long run

These two stocks could perform well in future years. More »

2 turnaround stocks that could make you rich

Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays. More »

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX). More »

Why this battered pharma stock could be a top turnaround buy

Roland Head selects his turnaround pick from two of this year's biggest pharma fallers. More »

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend? More »

These 2 battered stocks look set for a return to growth

These two hot recovery prospects certainly carry some risk, but they could provide great rewards for brave investors. More »

2 FTSE 350 growth stocks I’d buy ASAP

Now could be the perfect time to pick up shares in these two FTSE 350 (INDEXFTSE:NMX) growth companies. More »

Are these bombed-out pharma stocks worth buying?

Should you catch these falling knives? More »

2 ‘hot’ growth stocks I’d buy before it’s too late

Bilaal Mohamed explains why investors should consider these growth stocks before it's too late. More »

Why I’d buy and hold Hikma Pharmaceuticals plc for the next decade

Hikma Pharmaceuticals plc (LON: HIK) could be a stunning long-term growth stock. More »

2 FTSE 100 growth stocks to buy before it’s too late?

Royston Wild discusses the investment potential of two FTSE 100 (INDEXFTSE: UKX) growth shares. More »

These FTSE 100 stocks rocketed 20% in February. Can they keep going?

Royston Wild runs the rule over two FTSE 100 (INDEXFTSE: UKX) chargers. More »

Why this growth stock could soar 40%+ within 2 years

Stunning gains could be on the horizon for this company. More »

A dividend stock and a growth stock I’d buy in February

Edward Sheldon identifies a dividend powerhouse and a growth stock that offer value at present. More »

Kick-start 2017 with these explosive growth stocks

Bilaal Mohamed thinks these two pharmacetutical firms could be on the verge of spectacular gains in 2017. More »

2 top healthcare shares for growth investors right now

Are these the best healthcare stocks to buy for 2017? More »

2 defensive stocks looking attractive since recent falls

These defensive dividend growers are on sale. More »

Could Vectura Group plc grow to be a FTSE 100 company within 10 years?

Vectura Group plc (LON:VEC) could follow in the footsteps of Hikma Pharmaceuticals (LON:HIK), says G A Chester. More »

Which of these Footsie healthcare stars should you buy after today’s news?

Royston Wild discusses the investment prospects of two Footsie medical giants. More »

Why did shares in Hikma Pharmaceuticals plc and GlaxoSmithKline plc crash last week?

Shares in GlaxoSmithKline plc (LON: GSK) and Hikma Pharmaceuticals plc (LON: HIK) are crashing but should you sell? More »